FDA Needs Rule Change For DMAA Crackdown, Suit Says

Law360, New York (November 07, 2013, 2:38 PM ET) -- A weight loss and energy supplement maker hit the U.S. Food and Drug Administration with a lawsuit on Tuesday that accuses it of improperly issuing a detention order on products that contain a controversial stimulant, saying the agency must first go through a formal rule-making process.

Georgia-based Hi-Tech Pharmaceuticals Inc. said in its complaint, filed in D.C. federal court, that the FDA has not engaged in the rule-making process necessary to formally ban the stimulant dimethylamylamine, or DMAA, but still issued an administrative detention order against...
To view the full article, register now.